Key points from article :
In MS immune system attacks and breaks down myelin, causing loss of motor and sensory functions.
Researchers regenerated myelin with progenitor glial cells and transplanted them into mice with MS.
Transplanted cells migrated to damaged areas, transformed into new oligodendrocytes and restored myelin.
Oscine Therapeutics is preparing the cell therapy for clinical trials in MS and other glial diseases.
Potential therapy for other diseases marked by glial defects including Huntington’s.
Research by University of Rochester Medical Center, published in Cell Reports.
EBV targeted therapies and implanting stem cells with surface protein CD34 are other approaches to treat MS.
